Differential Outcomes following Optimization of Simian-Human Immunodeficiency Viruses from Clades AE, B, and C
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Virology"
DOI: 10.1128/jvi.01860-19
Abstract: We sought to enhance the infectivity of three SHIV stocks by optimization of a key residue in human immunodeficiency virus type 1 (HIV-1) Env (Env375). We developed the following three new simian-human immunodeficiency virus (SHIV)… read more here.
Keywords: immunodeficiency virus; virus; shiv 325ch; shiv ... See more keywords